SEC Filing Summary: India Globalization Capital, Inc. (IGC Pharma, Inc.)
Business Context and Reporting Period
This Form 8-K, dated February 13, 2015, serves as a current report for India Globalization Capital, Inc. (also referenced as IGC Pharma, Inc.). The filing announces the distribution of a press release regarding financial results for the third quarter ended December 31, 2014 (Fiscal Q3 2015), for the fiscal year ending March 31, 2015.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached press release (Exhibit 99.1), which is not included in the provided source text.
Material Changes
No material changes versus the prior comparable period are detailed in the body of this Form 8-K. The document solely references the issuance of the press release containing the comparative financial data.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, risk factors, contingencies, or unusual items. It functions strictly as a notification of the press release distribution.
Investor Verification Checklist
- Verify the specific revenue and net income figures for Fiscal Q3 2015 in the attached Exhibit 99.1 (Press Release).
- Confirm the company's current legal name and ticker symbol, as the filing references both "India Globalization Capital, Inc." and "IGC Pharma, Inc."
- Review the full press release for any material changes in operations or financial position not summarized in this 8-K.
- Check for subsequent filings that may provide updated liquidity or debt positions.